David F. Penson
- Pulmonary and Respiratory Medicine top 0.05%
- Oncology top 0.2%
- Surgery top 0.2%
- Urology top 0.05%
- Immunology top 1%
- Co-authors
- Philip W. KantoffPeter C. AlbertsenCelestia S. HiganoNeal D. ShoreMark W. FrohlichPaul F. SchellhammerEric J. SmallRobert Dreicer
- Topics
- Prostate Cancer Diagnosis and Treatment (181 papers)Prostate Cancer Treatment and Research (159 papers)Bladder and Urothelial Cancer Treatments (78 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David F. Penson
415 papers receiving 23.1k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Pulmonary and Respiratory Medicine 11.9k
- Oncology 6.9k
- Surgery 5.9k
- Urology 3.6k
- Immunology 2.3k
Countries citing papers authored by David F. Penson
This map shows the geographic impact of David F. Penson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David F. Penson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David F. Penson more than expected).
Fields of papers citing papers by David F. Penson
This network shows the impact of papers produced by David F. Penson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David F. Penson. The network helps show where David F. Penson may publish in the future.
Co-authorship network of co-authors of David F. Penson
This figure shows the co-authorship network connecting the top 25 collaborators of David F. Penson. A scholar is included among the top collaborators of David F. Penson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David F. Penson. David F. Penson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 54 | |
| 7 | 26 | |
| 8 | 5 | |
| 9 | 5 | |
| 10 | 20 | |
| 11 | The influence of provider characteristics and market forces on response to financial incentives. | 2 |
| 12 | Short term complications from transurethral resection of bladder tumor. | 43 |
| 13 | ACA, MACRA: What they mean for you, patients | 1 |
| 14 | 44 | |
| 15 | 34 | |
| 16 | 148 | |
| 17 | 42 | |
| 18 | Phase III bladder cancer chemoprevention trial with fenretinide. | 1 |
| 19 | 62 | |
| 20 | 6 |
About David F. Penson
David F. Penson is a scholar working on Urology, Pulmonary and Respiratory Medicine and Oncology, having authored 432 papers that have together received 23.7k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (181 papers), Prostate Cancer Treatment and Research (159 papers) and Bladder and Urothelial Cancer Treatments (78 papers). The work is most often cited by research in Urology (3.6k citations), Pulmonary and Respiratory Medicine (11.9k citations) and Oncology (6.9k citations). David F. Penson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Philip W. Kantoff, Peter C. Albertsen, Celestia S. Higano, Neal D. Shore, Mark W. Frohlich, Paul F. Schellhammer, Eric J. Small, Robert Dreicer, Yi Xu and Charles H. Redfern. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.